A new, early stage venture capital firm aimed at supporting University of Arizona technology spinoffs has made its first three investments. UA Venture Capital Fund LLC, founded earlier this year by Tucson businessmen Fletcher McCusker and Michael Deitch, made investments in startups Codelucida, which has developed error-correction technology for data storage drives; Regulonix, which is […]

POMPANO BEACH, Fla.–(BUSINESS WIRE)–Stimwave LLC, a medical device manufacturer and independent research institute headquartered in South Florida, today announced the appointment of industry veteran Steven Amelio to the position of Chief Financial Officer (CFO). Amelio is a senior financial executive with 30 years of experience in the medical device industry. Over his 20 year career […]

(GT Medical) MedTech Innovator, the premier nonprofit startup accelerator in the medical technology industry, today announced that 50 companies have been selected to participate in the organization’s four-month 2018 program, featuring the industry’s most promising medical technologies from around the globe. The 2018 cohort features 25 early-stage and 25 mid-stage companies with transformative device, diagnostic, […]

Salutaris Medical Devices, Inc. announced the first subject was treated in a multi-center clinical trial investigating the use of its ophthalmic brachytherapy device to treat neovascular Age-related Macular Degeneration (nAMD) on May 23, 2018.  Dr. Gregg Kokame, Principal Investigator (PI) at the clinical site in Honolulu successfully performed the first procedure using the SMD-DA device on May […]

Regenesis Biomedical, a Scottsdale-based medical device company, has initiated a multi-center, randomized clinical trial assessing the Provant® Therapy System for relieving symptoms of painful diabetic distal symmetric peripheral neuropathy (DSPN). Painful neuropathy affects over 3 million people in the United States, resulting in nerve damage in the extremities such as tingling, numbness, pain and sensitivity […]

HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM) (“HTG”), a provider of instruments, reagents and services for molecular profiling applications, and Firalis S.A. (“Firalis”), a provider of bioanalytical services and biomarker-based products and services, today announced a non‑exclusive license and supply agreement (“Agreement”) that will enable Firalis to commercialize a next‑generation sequencing (NGS)‑based theranostic product and services to […]

For some, the words “financial aid” stirs up reminders of grueling applications and the anxiety of coping with skyrocketing college tuition. Phoenix-based CampusLogic aims to chip away at some of those challenges by helping institutions manage and award financial aid to more students, as well as reduce student borrowing by connecting colleges with private grant […]

CampusLogic, the leading student financial services (SFS) platform, today announced $55 million in funding led by JMI Equity, a growth equity firm focused on investing in leading software companies.  Founded in 2011, CampusLogic is a market leader in SFS software with nearly 500 higher education customers that serve more than three million students. CampusLogic, which […]

HTG Molecular Diagnostics, Inc.(Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the issuance of Japan Patent Number 6290202 for “Nuclease Protection Methods for Detection of Nucleotide Variants.” The patented technology involves a nuclease-protection method using wild‑type and variant probes competing for binding to a target nucleic acid molecule, such […]